The ?ErectoFix device in the recovery of chronic prostatitis

Evaluation of the effect of ErectoFix device in solving chronic prostatitis symptoms and complications

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20111121008146N47

Enrollment

Registered

2024-11-16

Start date

2024-12-21

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic prostatitis. Chronic prostatitis

Interventions

Intervention group: ErectoFix device is a combination of waves and radio frequencies, with wavelengths ranging from 430 to 690 nanometers and a power output of 400 milliwatts. Energy transfer is facil

Eligibility

Sex/Gender

Male

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Men with chronic prostatitis Prostate specific antigen less than 4 mg/dL

Exclusion criteria

Exclusion criteria: Bladder stones Urinary tract infection History of urological surgery leading to nerve cutting History of trauma to the genital area that caused neurological or vascular defects in the area Neurogenetic bladder

Design outcomes

Primary

Measure	Time frame
Chronic Prostate Symptom. Timepoint: before and after intervention. Method of measurement: Chronic prostatitis symptom index questionnaire (NIH-CPSI).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadreza Razzaghi

Shahid Beheshti University of Medical Sciences

morezarazaghi@gmail.com+98 21 2271 8001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026